Table 1 Baseline characteristics.
Clinical characteristics | |
|---|---|
Age, years | 62.9 ± 9.6 |
Male, % | 72 |
Body mass index, kg/m2 | 28.9 ± 3.9 |
Current smokers, % | 28 |
Chronic obstructive pulmonary disease, % | 32 |
Coronary artery disease, % | 32 |
Hypertension, % | 76 |
Diabetes mellitus, % | 8 |
Laboratory data | |
Haemoglobin, g/L | 13.4 ± 1.6 |
Sodium, mmol/L | 137.7 ± 4.1 |
Potassium, mmol/L | 4.4 ± 0.4 |
eGFR, mL/min/1.73 m2 | 70.8 ± 20.7 |
Glucose, mg/dL | 106.6 ± 20.9 |
C-reactive protein, mg/dL | 2.0 (1.0; 10.5) |
Cardiac parameters | |
Left ventricular mass index, gr/m2 | 128.7 ± 28.1 |
Left ventricular ejection fraction, % | 34.7 ± 7.7 |
Systolic blood pressure, mmHg | 122.5 ± 14.4 |
Heart failure etiology, % | |
- Ischemic | 42 |
- Idiopathic | 25 |
- Valvular | 8 |
- Other aetiologies/cardiomyopathies | 25 |
NYHA class, % | |
- II | 64 |
- III | 36 |
Treatment | |
Furosemide, % | 88 |
ACEi or ARB, % | 80 |
Mineralocorticoid antagonists, % | 48 |
Betablocker, % | 84 |
Digoxin, % | 16 |
Devices, % | |
- Implantable cardiac defibrillator | 24 |
- Cardiac resynchronization therapy | 32 |
